What if a hospital medicine change is missing from the GP record?

Protect the next prescription first

A patient leaves hospital with a new medicine, a stopped medicine or a changed dose. The GP repeat list still shows the pre-admission regimen. A repeat request arrives, a care worker asks for clarification, or the community pharmacy flags a mismatch. The practice may not have received the discharge summary yet, or it may be in a correspondence queue awaiting clinical review. The immediate risk is that a new prescription or supply follows an out-of-date list. Establish what the patient is taking now and who can make a safe prescribing decision before an old repeat is issued.

NICE's primary-care medicines reconciliation quality statement says that people discharged from a care setting should have a reconciled medicine list in the GP record within one week of the practice receiving the information and before a new prescription or supply is issued. The one-week point runs from the GP practice receiving information, not automatically from the date the patient left hospital. It is a quality standard, and urgent clinical need may require an immediate controlled decision before the full routine workflow is complete. CQC's GP correspondence guidance says discharge letters and medicine changes need a safe processing system with clear clinical accountability.

Flag the pending reconciliation to the relevant prescriber and medicines team. Do not allow an administrative update to the list to stand in for clinical approval. If the patient has an urgent supply need, a competent prescriber should assess the available discharge information, current medicines, allergies, monitoring and clinical context, then decide on an appropriate prescription or alternative. This article does not give a universal rule to stop all medicines or issue a bridging prescription. Those are patient-specific decisions.

This page owns an incoming discharge medicine change that is missing or unreconciled in the GP record and the first safe prescribing decision. The care-home hospital-return reconciliation draft owns the resident's care-home administration and MAR handover. The GP test-results backlog draft owns results queues. The GP system-outage draft owns downtime records. These may intersect, but the missing medicine change creates a distinct prescribing and communication journey.

Establish which information is available and reliable

Find the discharge summary, hospital prescription, patient-held list, community pharmacy information and any specialist letter. Check the date and version of each. A preliminary discharge list may differ from the final one. A patient may have had a medicine stopped after the summary was prepared. An outpatient letter may recommend a change but not transfer prescribing responsibility. Do not copy a medicine from one document into the repeat list without resolving these questions. Record what sources were used and which details remain uncertain.

If the discharge summary is missing, contact the discharging service through the approved clinical route. State the patient identity, discharge date, information needed and urgency. A request sent to a general mailbox is not enough if a repeat prescription is due today. Use direct clinical or pharmacy contact when the risk warrants it, and record the advice given, by whom and when. If the hospital has not yet supplied a final list, the GP prescriber must decide how to manage the interim period safely, including whether specialist input or urgent assessment is needed.

Ask the patient or carer what was actually supplied and taken, while recognising the limits of memory and packaging. Medicines may be in a discharge bag, blister pack, care-home stock or at a pharmacy. The label can show dose and timing, but may not explain why an old medicine stopped. A patient can be taking both the new and old versions if the change was not understood. Use a structured conversation, check physical packs where feasible and involve the community pharmacist or care provider with consent and appropriate information sharing. Do not ask a patient to choose between conflicting professional instructions without clinical support.

Verify the transfer channel

The practice should know how discharge information normally arrives: electronic message, clinical system task, secure mailbox or letter. Check whether the message failed to transmit, arrived under a different patient, was scanned but not tasked, or sat with a clinician who was absent. A paper letter may be physically present yet unavailable to the prescriber. The issue is not solved by finding the document if the required medicine decision remains open.

Record the point of failure. Was it upstream transmission, practice receipt, triage, clinical review, prescribing update or communication to patient and pharmacy? A process fix for one stage will not address another. For example, a new scanning checklist will not help if a clinician reviews letters but does not cancel an old repeat. A clinical review date in a dashboard is not proof that the patient list and next supply were corrected.

Reconcile the medicine list clinically

Compare the pre-admission GP list with the discharge regimen and what the person is actually taking. Identify medicines started, stopped, changed, continued or temporarily withheld. Check dose, route, frequency, indication, duration, monitoring, allergies and any special supply route. Some discrepancies are intended clinical changes; others are errors or unclear documentation. Record each discrepancy and how it was resolved. The aim is one accurate, usable current list, not simply matching two screens.

Assign reconciliation to a competent clinician or pharmacy professional under the practice's approved protocol. CQC says trained non-clinical staff can identify where a change may be needed and route it to a prescriber, but the prescriber remains accountable for the prescription they sign. Do not allow a receptionist to interpret a specialist dose change or to reassure a patient that two conflicting lists are equivalent. Administrative staff can perform defined tasks with training, supervision and escalation, while clinical decisions stay with appropriate professionals.

Prioritise cases where a wrong repeat could cause immediate harm. A high-risk medicine, narrow therapeutic window, major dose change, recent adverse reaction, complex multi-medicine regimen or vulnerable patient may need faster clinical review. The exact risk depends on the medicine and patient. Do not use a blanket list that makes every discharge change “routine within seven days”. NICE's quality standard says within one week of the practice receiving information and before a new prescription or supply. The practice should act sooner when clinical need requires it.

If the discharge letter is ambiguous, seek clarification from the discharging prescriber or specialist team. A line such as “GP to continue” may not resolve who monitors tests or when the medicine is reviewed. Record the agreed responsibility, any planned monitoring, and how the patient will obtain the next supply. If a shared-care arrangement is proposed, follow the applicable local policy rather than assuming that a discharge letter alone transfers responsibility. Do not delay an urgent patient safety decision while a broader contractual discussion continues.

Handle an immediate repeat request carefully

When a repeat request is pending, pause automatic processing of the affected item until a prescriber reviews the discrepancy. Tell the patient and pharmacy that the request is being clinically checked and provide a safe contact route. This is not a blanket instruction to withhold treatment. The prescriber may issue a verified supply, contact the hospital or arrange urgent review according to the facts. Keep an owner and deadline so “held for review” does not become an unnoticed missed dose.

Check whether the old medicine is already in a batch of prescriptions sent to the pharmacy. A correction to the GP list may not cancel an electronic prescription already issued or a medicine already dispensed. The prescriber should coordinate with the pharmacy and patient through the appropriate route. Document whether the earlier item was cancelled, supplied or taken, and whether clinical follow-up is needed. A tidy GP record can conceal a dangerous physical stock mismatch in the patient's home.

Update the record and communicate the plan

Once the clinical decision is made, update the active medicine list, repeat templates, acute items and relevant monitoring or recall tasks. Preserve the discharge summary and reconciliation note. Explain the reason for each material change, any unresolved issue and the next review date. Make sure a locum or out-of-hours clinician can see the current plan. If an old medicine was stopped, check that it cannot be reissued from an active repeat template. If a temporary medicine has an end date, record how that end point will be reviewed.

Tell the patient what to take, what to stop, how to obtain supply and what symptoms or problems should prompt urgent advice. Use a communication format they can understand. Check whether they have old packs at home or a monitored dosage system. If a carer, care home or district nurse administers medicines, send the updated instruction through an approved route and confirm receipt where the risk is high. A record update only at the GP surgery does not automatically reach everyone who supports the person.

Coordinate with the community pharmacy. NHS England's Discharge Medicines Service exists to improve communication about medicine changes when people leave hospital, but its use and referral for this patient must be confirmed. Do not assume every discharge is automatically enrolled or that a pharmacy has the final hospital list. Share the relevant, verified information lawfully and clarify who will explain or dispense the next supply. A pharmacy query can be an early warning that the reconciliation process has not reached the front line.

Make monitoring and follow-up explicit

A changed medicine may require a blood test, blood pressure check, symptom review or specialist follow-up. The discharge summary may assign these tasks ambiguously. A clinician should decide who requests and reviews each test, what action is needed if a result does not arrive, and how the patient will be contacted. Link to the GP test-results owner if the follow-up becomes a results-pathway problem. Do not close the medicines reconciliation simply because the list has been edited while a critical monitoring task has no owner.

Where a hospital appointment or specialist review is pending, record what the GP will do in the interim and when the responsibility is expected to change. If a specialist letter later contradicts the discharge summary, reconcile again. The current list is a maintained clinical record, not a one-time copy of the discharge paper. Tell the patient if the plan changes and check downstream providers have the latest instruction.

Investigate how the information was missed

Review the correspondence workflow after the patient is safe. Was the summary received? Was it coded under the correct patient? Did an administrator identify a medicine change and send it to a prescriber? Was the task stuck with an absent clinician? Did the prescriber update the list but not the repeat? Did the pharmacy receive an old issue before the change? Trace the handover with dates and owners. Avoid calling the whole event “letter processing delay” if the actual failure was clinical reconciliation or outbound communication.

CQC's GP mythbuster 46 expects practices to show that their correspondence process is effective and to assess and audit it. Sample other recent discharges to see whether the same failure occurred. Focus on the route and risk, not merely a count of letters completed. Compare receipt, clinical review, medicine update, first new prescription and patient communication. If one queue is heavily backlogged, triage higher-risk medicine changes first while restoring the routine process. A broad backlog may need its own incident and resourcing review.

Use the event to test absence cover and role clarity. A discharge message may arrive Friday afternoon and be allocated to a clinician on leave. A non-clinical worker may assume the prescriber changed medicines because the letter was filed. A prescriber may assume a pharmacist will perform reconciliation. Put the handoff in writing: who identifies changes, who makes clinical decisions, who updates templates, who communicates and who verifies. Train staff on the exact escalation signal and audit a sample after the change. A reminder email alone is not an effectiveness test.

If a patient was harmed or there was a near miss, use the patient safety response route and assess openness, candour and notification duties on the facts. Do not assert that every late discharge letter is automatically reportable to CQC. Preserve the clinical care record and governance review separately but linked. The patient may need a medicine review or monitoring before the incident investigation is complete. Clinical action and learning should proceed in parallel.

A workable reconciliation evidence trail

The practice should be able to follow the handover from discharge to the next safe supply:

This is not a substitute for the clinical record. The full reconciliation and patient decision belong in an approved clinical system. A governance register can track that a case was resolved and a process tested without displaying names or medicine details widely. Set an open owner for unresolved discrepancies. Do not close a case solely because the hospital letter was scanned.

NICE's quality statement gives a useful timing test: within one week of receiving information and before a new prescription or supply. It should be interpreted with clinical urgency. A patient asking for a high-risk medicine today cannot wait until day seven merely because a weekly target has not expired. Equally, the practice cannot be judged to have delayed from the discharge date if it had not received the information, though it still needs to act safely once a risk is identified. Record both dates to analyse the transfer system fairly.

Keep Complys in its verified scope

The Complys GP and clinic page describes a compliance layer alongside clinical and patient-record systems. Subject to its actual configuration, a practice could use it to assign correspondence-process audits, track training, retain anonymised reconciliation findings and follow corrective actions. The patient-level medicine list, prescription, clinical decision and pharmacy communication belong in approved clinical and medicines systems. This draft does not claim that Complys receives hospital summaries, reconciles medicines, updates GP repeats or sends pharmacy instructions.

Use the governance layer for system learning rather than parallel patient records. A task can say “audit ten recent discharge reconciliation cases by this date” and record the aggregate outcome. It need not attach identifiable discharge letters. If a specific incident must be referenced, restrict access and use a minimal case identifier under local policy. A completion reminder cannot show that the next prescription matched the verified list; that needs a clinical record and direct check.

CTA: Review how Complys can track GP correspondence audits and corrective actions while clinical reconciliation stays in the patient-record system. Ask for a walkthrough using a real handover control. Related tool opportunity: A discharge-medicine handover audit sheet with receipt, clinical review, list update, first supply and communication checks. Clinical pharmacy and information-governance review required before release. Internal links out: care-home hospital-return medicines reconciliation; GP test-results backlog; GP clinical-system outage; incident corrective-action effectiveness. Internal links in proposed: Broad GP CQC guide, GP correspondence owner if separately validated and care-home transfer owner for cross-setting handover.